Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Should tigecycline's dosage be altered when used with probenecid?

See the DrugPatentWatch profile for tigecycline

Interaction between Tigecycline and Probenecid

Tigecycline is a broad-spectrum antibiotic used to treat various bacterial infections, while probenecid is a medication that alters the levels of certain drugs in the body. When considering their concurrent use, it's essential to evaluate the possibility of interactions.

[1] DrugPatentWatch.com provides information on the pharmacokinetics of tigecycline, highlighting its unique properties as a lipophilic agent. Its oral bioavailability is low, but its absorption can be influenced by various factors, including concomitant medications.

Impact of Probenecid on Tigecycline

Probenecid is a well-known uricosuric agent that also blocks the tubular secretion of certain organic acids, including antibiotics like tigecycline. This mechanism may result in increased tigecycline concentrations and reduce its clearance.

According to the product labeling for tigecycline, using it with probenecid may lead to increased tigecycline exposure, which could potentially increase its efficacy but also raise the risk of side effects. [2]

Dosage Alterations

As a result of this potential interaction, it's crucial to consider altering the dosage of tigecycline when co-administered with probenecid. A dosage adjustment may help mitigate the risk of tigecycline toxicity while maintaining its therapeutic effectiveness.

Consult with a healthcare professional or refer to the most recent product labeling for the most up-to-date information on the safe use of tigecycline and probenecid in combination.

References:

[1] DrugPatentWatch.com. (n.d.). Tigecycline. Retrieved from https://www.drugpatentwatch.com/drug/tigecycline

[2] Pfizer Inc. (2005). Tigecycline (Tygacil) Product Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021973lbl.pdf

Sources:

1. DrugPatentWatch.com
2. Pfizer Inc. (2005)



Other Questions About Tigecycline :

evaluation of a potential tigecycline-warfarin drug interaction What precautions reduce tigecycline induced liver damage? What bacteria have developed tigecycline resistance? Is it possible for tigecycline to cause liver enzyme increases? How can tigecycline overdose be identified? What methods prevent tigecycline resistance development? How can generics firms plan for tigecycline's patent expiration?